EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain and Modulation via Direct Interactions with DNA Abasic Sites: Understanding the Mechanisms Involved in Castration-Resistant Prostate Cancer

Shangze Xu iD, Matthew D Kondal, Ayaz Ahmad, Ruidi Zhu, Lanyu Fan, Piotr Zaborniak, Katrina S Madden iD, João V de Souza, Agnieszka K Bronowska iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shangze Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry-School of Natural and Environmental Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK. Hauptthemen laut MEDLINE: Receptors, Androgen, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Newcastle University School of Natural and Environmental Sciences, EPSRC-AstraZeneca iCASE scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The androgen receptor (AR) is an important drug target in prostate cancer and a driver of castration-resistant prostate cancer (CRPC). A significant challenge in designing effective drugs lies in targeting constitutively active AR variants and, most importantly, nearly all AR variants lacking the ligand-binding domain (LBD). Recent findings show that an AR’s constitutive activity may occur in the presence of somatic DNA mutations within non-coding regions, but the role of these mutations remains elusive. The discovery of new drugs targeting CRPC is hampered by the limited molecular understanding of how AR binds mutated DNA sequences, frequently observed in prostate cancer, and how mutations within the protein and DNA regulate AR-DNA interactions. Using atomistic molecular dynamics (MD) simulations and quantum mechanical calculations, we focused our efforts on (i) rationalising the role of several activating DBD mutations linked to prostate cancer, and (ii) DBD interactions in the presence of abasic DNA lesions, which frequently occur in CRPC. Our results elucidate the role of mutations within DBD through their modulation of the intrinsic dynamics of the DBD-DNA ternary complex. Furthermore, our results indicate that the DNA apurinic lesions occurring in the androgen-responsive element (ARE) enhance direct AR-DNA interactions and stabilise the DBD homodimerisation interface. Moreover, our results strongly suggest that those abasic lesions may form reversible covalent crosslinks between DNA and lysine residues of an AR via a Schiff base. In addition to providing an atomistic model explaining how protein mutations within the AR DNA-binding domain affect AR dimerisation and AR-DNA interactions, our findings provide insight into how somatic mutations occurring in DNA non-coding regions may activate ARs. These mutations are frequently observed in prostate cancer and may contribute to disease progression by enhancing direct AR-DNA interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenProstatic Neoplasms, Castration-ResistantMaleHumansAndrogensProtein DomainsDNA

Stichwörter der Autor:innen

DNA-protein adductsDNA-protein interactionsandrogen receptorcastration-resistant prostate cancerdimerisationmolecular dynamics simulationsprotein-protein interactions

Substanzen

Receptors, AndrogenAndrogensDNA

Autor:innen und Institutionen

  • Chemistry-School of Natural and Environmental Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
  • Newcastle University Centre for Cancer, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
  • School of Engineering, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK.

ORCID-Profile: Shangze Xu, Katrina S Madden, Agnieszka K Bronowska

Förderung

  • Engineering and Physical Sciences Research Council
  • Newcastle University School of Natural and Environmental Sciences
  • EPSRC-AstraZeneca iCASE scholarship
  • EPSRC scholarship
  • EPSRC funding

Zitieren

APA

Xu, S., Kondal, M. D., Ahmad, A., Zhu, R., Fan, L., Zaborniak, P., Madden, K. S., de Souza, J. V., & Bronowska, A. K. (2023). Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain and Modulation via Direct Interactions with DNA Abasic Sites: Understanding the Mechanisms Involved in Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021270

Vancouver

Xu S, Kondal MD, Ahmad A, Zhu R, Fan L, Zaborniak P, et al. Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain and Modulation via Direct Interactions with DNA Abasic Sites: Understanding the Mechanisms Involved in Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021270

BibTeX
@article{Xu2023,
  author = {Xu, Shangze and Kondal, Matthew D and Ahmad, Ayaz and Zhu, Ruidi and Fan, Lanyu and Zaborniak, Piotr and Madden, Katrina S and de Souza, João V and Bronowska, Agnieszka K},
  title = {Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain and Modulation via Direct Interactions with DNA Abasic Sites: Understanding the Mechanisms Involved in Castration-Resistant Prostate Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021270}
}
Kostenlos starten →